Altering the reaction specificity of eukaryotic ornithine decarboxylase
Altering the reaction specificity of eukaryotic ornithine decarboxylase
复制标题
DOI:
10.1021/bi001209s
复制
发表时间:
2000-09-19
期刊:
影响因子:
2.9
通讯作者:
Phillips, MA
中科院分区:
文献类型:
--
作者:
Jackson, LK;Brooks, HB;Phillips, MA
Ornithine decarboxylase (ODC) catalyzes the first committed step in the biosynthesis of polyamines, and it has been identified as a drug target for the treatment of African sleeping sickness, caused by Trypanosoma brucei. ODC is a pyridoxal 5'-phosphate (PLP) dependent enzyme and an obligate homodimer, X-ray structural analysis of the complex of the T. brucei wild-type enzyme with the product putrescine reveals two structural changes that occur upon ligand binding: Lys-69 is displaced by putrescine and forms new interactions with Glu-94 and Asp-88, and the side chain of Cys-360 rotates into the active site to within 3.4 Angstrom of the imine bond. Mutation of Cys-360 to Ala or Ser reduces the k(cat) of the decarboxylation reaction by 50- and 1000-fold, respectively. However, HPLC analysis of the products demonstrates that the mutant enzymes almost exclusively catalyze a decarboxylation-dependent transamination reaction to form pyridoxamine 5-phosphate (PMP) and gamma-aminobutyraldehyde, instead of PLP and putrescine. This side reaction arises when the decarboxylated substrate intermediate is protonated at C4' of PLP instead of at the C-alpha of substrate. For the reaction catalyzed by the wild-type enzyme, this side reaction occurs infrequently (